Uncategorised - European Medical Journal

Sex-Specific Differences of Human Skeletal Muscle

Exercise is a potent skeletal muscle stimulus and the most effective strategy to prevent weight loss-related muscle loss and Type 2…

Youth-Onset Type 2 Diabetes: An Awakening Epidemic

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive clinical course…

EASD 2024 Abstract Highlights

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection against the…

EASD 2024 Interview: Francesco Giorgino

I was fascinated by hormones from when I first learnt about hormones as molecules that can carry a signal from one tissue or cell to…

CDC Warns of Oropouche Virus Sexual Transmission Risk

Ninety cases of imported Oropouche virus have been reported across five states, primarily in Florida, according to the U.S. Centers for Disease Control and Prevention (CDC).

Avian Flu and Mpox: Emerging Pandemic Risks

The Global Preparedness Monitoring Board (GPMB) has released its latest annual report, spotlighting avian flu and mpox as significant emerging threats with pandemic potential.

How to maximise your year-end medical affairs and marketing budget

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital

Methods for Detecting Pancreatic Neoplasms

A novel deep-learning method utilising endoscopic ultrasound images could significantly enhance the detection of pancreatic neuroendocrine neoplasms according to recent research

Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.